Sulfasalazine-induced drug rash with eosinophilia and systemic symptoms syndrome in a seronegative spondyloarthritis patient: A Case report (Record no. 15863)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | a |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20211231113227.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 211231b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | AIKTC-KRRC |
| Transcribing agency | AIKTC-KRRC |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 15282 |
| Author | Sah, Naresh |
| 245 ## - TITLE STATEMENT | |
| Title | Sulfasalazine-induced drug rash with eosinophilia and systemic symptoms syndrome in a seronegative spondyloarthritis patient: A Case report |
| 250 ## - EDITION STATEMENT | |
| Volume, Issue number | Vol.53(5), Sep-Oct |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Mumbai |
| Name of publisher, distributor, etc. | Wolter Kluwer |
| Year | 2021 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Pagination | 391-393p. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The objectives were to evaluate drug rash with eosinophilia and systemic symptoms syndrome due<br/>to sulfasalazine and to carry out the pharmacoeconomic assessment associated with this adverse<br/>drug reaction (ADR). A 37‑year woman was presented with rashes, fever, cough, and dyspnea.<br/>In the past 3 months, she was on sulfasalazine for inflammatory polyarthritis and seronegative<br/>spondyloarthritis. The diagnosis was based on raised eosinophils count, breathing difficulty, and<br/>typical pattern of rashes. Significant improvement was seen after discontinuation of sulfasalazine<br/>and with the initiation of parenteral corticosteroids. The casualty of this ADR was “probable” based on<br/>RegiSCAR, WHO, and Naranjo casualty assessment scales. Preventability, severity was assessed<br/>and total cost for management of the ADR was found to be ` 12,126. Thus, ADRs not only adds to<br/>patient sufferings but also increase the economic burden. Health‑care providers need to be made<br/>aware of potentially fatal ADRs associated with sulfa drugs and should be keen to report such ADRs<br/>to drug safety authorities. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| 9 (RLIN) | 4774 |
| Topical term or geographic name entry element | PHARMACOLOGY |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 15283 |
| Co-Author | Ramaiah, Balakeshwa |
| 773 0# - HOST ITEM ENTRY | |
| International Standard Serial Number | 0253-7613 |
| Title | Indian Journal of Pharmacology |
| Place, publisher, and date of publication | Andheri - Mumbai Wolters Kluwer India Private Limited |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| URL | https://www.ijp-online.com/temp/IndianJPharmacol535391-2153833_055858.pdf |
| Link text | Click here |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Articles Abstract Database |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | School of Pharmacy | School of Pharmacy | Archieval Section | 31/12/2021 | 2021-2022680 | 31/12/2021 | 31/12/2021 | Articles Abstract Database |